Home > Financial Ratios > THYROCARE TECHNOLOGIES

THYROCARE TECHNOLOGIES
Core EBITDA Growth

    Back to All Ratios
THYROCARE TECHNOLOGIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for THYROCARE TECHNOLOGIES
Please provide your vote to see the results

THYROCARE TECHNOLOGIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 13.12-50.5844.251.919.78

What is the latest Core EBITDA Growth ratio of THYROCARE TECHNOLOGIES ?

The latest Core EBITDA Growth ratio of THYROCARE TECHNOLOGIES is 13.12 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202413.12
Mar2023-50.58
Mar202244.25
Mar20211.91
Mar20209.78

How is Core EBITDA Growth of THYROCARE TECHNOLOGIES Trending?

Years Core EBITDA Growth % Change
Mar2024 13.12
Positive
Mar2023 -50.58
Negative
Mar2022 44.25
2,216.75
Mar2021 1.91
-80.47
Mar2020 9.78 -

Other Financial Ratios of THYROCARE TECHNOLOGIES


Compare Core EBITDA Growth ratio of peers of THYROCARE TECHNOLOGIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
THYROCARE TECHNOLOGIES ₹4,323.2 Cr 2.2% -10.9% 29.5% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹109,395.0 Cr 1.7% -7% 42.8% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹98,797.3 Cr 0.5% -3.1% 12.1% Stock Analytics
FORTIS HEALTHCARE ₹49,151.6 Cr 3.8% -8.8% 47.4% Stock Analytics
GLOBAL HEALTH ₹31,387.1 Cr 9% 9.3% -6.7% Stock Analytics
NARAYANA HRUDAYALAYA ₹28,052.6 Cr 1.6% 3.2% -0.6% Stock Analytics


THYROCARE TECHNOLOGIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
THYROCARE TECHNOLOGIES

2.2%

-10.9%

29.5%

SENSEX

0.7%

-0.1%

8.8%


You may also like the below Video Courses